Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%
CONSUMER healthcare firm Haleon said on Monday (Mar 18) that US drugmaker Pfizer, its top shareholder, will sell down its stake in...
Pfizer inflammatory bowel disease drug wins EU approval
PFIZER’S drug to treat patients with an inflammatory bowel disease called ulcerative colitis has been approved by the European Commission, the company...
Pfizer posts surprise quarterly profit on resilient Covid products demand
PFIZER reported a surprise quarterly profit on Tuesday (Jan 30), helped by its cost-cutting measures and as the US government returned fewer...
BioNTech predicts return to revenue growth in 2025
BIONTECH on Tuesday (Jan 9) said it would return to revenue growth in 2025, forecasting that the ongoing decline in its Covid-19...
Expiring Pfizer Covid drug doses set to cost Europe US$2.2 billion
STOCKPILES of Pfizer’s Paxlovid worth US$2.2 billion are set to expire by the end of next month in Europe and the UK...
Drugmakers set to raise US prices on at least 500 drugs in January
DRUGMAKERS including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 unique drugs in...
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
PFIZER on Wednesday (Dec 13) forecast 2024 revenue and profit below Wall Street expectations, sending its shares down 6 per cent in...
Pfizer gets OK for US$43 billion Seagen deal after donating cancer drug rights
PFIZER said on Tuesday (Dec 12) it has agreed to donate the rights of royalties from sales of cancer drug Bavencio to...
Weight-loss drugs are a gold mine, and just as elusive
PFIZER announced on Friday (Dec 1) that it’s dropping development of an experimental weight-loss pill after patients experienced uncomfortable side effects in...
Pfizer swings to quarterly loss as Covid product demand slumps
PFIZER on Tuesday (Oct 31) reported its first quarterly loss since 2019, as demand fell for its Covid products and it recorded...